NCT04557436View on ClinicalTrials.gov

TT52CAR19 Therapy for B-cell Acute Lymphoblastic Leukaemia (B-ALL)

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

August 12, 2020

Primary Completion Date

March 5, 2024

Study Completion Date

March 5, 2024

Conditions
B Acute Lymphoblastic Leukemia
Interventions
DRUG

PBLTT52CAR19

gene therapy

Trial Locations (1)

Unknown

Great Ormond Street Hospital, London

All Listed Sponsors
collaborator

University College, London

OTHER

lead

Great Ormond Street Hospital for Children NHS Foundation Trust

OTHER

NCT04557436 - TT52CAR19 Therapy for B-cell Acute Lymphoblastic Leukaemia (B-ALL) | Biotech Hunter | Biotech Hunter